Medical treatment of constipation
- PMID: 20011345
- PMCID: PMC2780140
- DOI: 10.1055/s-2005-870887
Medical treatment of constipation
Abstract
Various agents are used for the medical management of chronic constipation, but few of these have been adequately studied. This article specifically examines the medical treatment of chronic constipation and the available data concerning bulk agents, lubricating agents, stimulants, and osmotic laxatives, used alone and in combination. Most experts consider dietary fiber or medicinal bulk agents to be the initial therapeutic option for the treatment of chronic constipation. If fiber is not successful or poorly tolerated, subsequent treatments may include saline osmotic laxatives, lactulose, 5-hydroxytryptamine4 (5-HT(4)) agonists (tegaserod), or stimulants such as senna or bisacodyl. Recent data also demonstrate both polyethylene glycol laxative and tegaserod to be safe and effective as initial therapy for chronic constipation.
Keywords: 5-HT4 agonists; Constipation; fiber; laxatives; osmotic agents; polyethylene glycol.
Similar articles
-
Current treatment options for chronic constipation.Rev Gastroenterol Disord. 2004;4 Suppl 2:S34-42. Rev Gastroenterol Disord. 2004. PMID: 15184812
-
Management of chronic constipation in patients with diabetes mellitus.Indian J Gastroenterol. 2017 Jan;36(1):11-22. doi: 10.1007/s12664-016-0724-2. Epub 2016 Dec 17. Indian J Gastroenterol. 2017. PMID: 27987136 Review.
-
Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).Evid Based Child Health. 2013 Jan;8(1):57-109. doi: 10.1002/ebch.1893. Evid Based Child Health. 2013. PMID: 23878124 Review.
-
[Constipation: Initial evaluation and diagnostic approach].Rev Gastroenterol Mex. 2005 Jul-Sep;70(3):312-22. Rev Gastroenterol Mex. 2005. PMID: 17063788 Review. Spanish.
-
What is the Evidence for Over the Counter Laxatives to Treat Childhood Constipation?Curr Gastroenterol Rep. 2021 Oct 12;23(11):19. doi: 10.1007/s11894-021-00818-1. Curr Gastroenterol Rep. 2021. PMID: 34637057 Review.
Cited by
-
Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.Mov Disord. 2018 Mar;33(3):372-390. doi: 10.1002/mds.27344. Mov Disord. 2018. PMID: 29508455 Free PMC article. Review.
-
Evaluating the effectiveness of probiotics in relieving constipation in Parkinson's disease: A systematic review and meta-analysis.Heliyon. 2023 Mar 4;9(3):e14312. doi: 10.1016/j.heliyon.2023.e14312. eCollection 2023 Mar. Heliyon. 2023. PMID: 36938477 Free PMC article. Review.
-
New Understanding on the Pathophysiology and Treatment of Constipation in Parkinson's Disease.Front Aging Neurosci. 2022 Jun 22;14:917499. doi: 10.3389/fnagi.2022.917499. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35813960 Free PMC article. Review.
-
Evaluation and management of constipation.Ochsner J. 2008 Spring;8(1):25-31. Ochsner J. 2008. PMID: 21603553 Free PMC article.
-
One-day oral polyethylene glycol based cleanout is effective for pre-colonoscopy preparation in children.BMC Gastroenterol. 2018 Nov 7;18(1):170. doi: 10.1186/s12876-018-0895-7. BMC Gastroenterol. 2018. PMID: 30404598 Free PMC article.
References
-
- Di Palma J A. Current treatment options for chronic constipation. Rev Gastroenterol Disord. 2004;4:S34–S42. - PubMed
-
- Meshkinpour H, Selod S, Movahedi H, et al. Effects of regular exercise in management of chronic idiopathic constipation. Dig Dis Sci. 1998;43:2379–2383. - PubMed
-
- Young R J, Beerman L E, Vanderhoff J A. Increasing oral fluids in chronic constipation in children. Gastroenterol Nurs. 1998;21:156–161. - PubMed
-
- Madoff R D, Fleshman J W. AGA technical review on the diagnosis and care of patients with anal fissure. Gastroenterology. 2003;124:235–245. - PubMed
-
- Locke G R, III, Pemberton J H, Phillips S F. AGA Medical Position Statement: guidelines on constipation. Gastroenterology. 2000;119:1761–1778. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources